Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy in Patients With Advanced Ovarian Cancer (OVHIPEC-1): Final Survival Analysis of a Randomised, Controlled, Phase 3 Trial.

Authors: Aronson, S. Lot, Lopez-Yurda, Marta, Koole, Simone N., Schagen van Leeuwen, Jules H., Schreuder, Hendrik W. R., Hermans, Ralph H. M., de Hingh, Ignace H. J. T., van Gent, Mignon D. J. M., Arts, Henriêtte J. G., van Ham, Maaike A. P. C., van Dam, Peter A., Vuylsteke, Peter, Aalbers, Arend G. J., Verwaal, Victor J., Van de Vijver, Koen K., Aaronson, Neil K., Sonke, Gabe S., van Driel, Willemien J., L. V. L.

Source: Obstetrical & Gynecological Survey; Feb2024, Vol. 79 Issue 2, p96-98, 3p

Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial.

Authors: Koole, Simone N., Schouten, Philip C., Hauke, Jan, Kluin, Roel J. C., Nederlof, Petra, Richters, Lisa K., Krebsbach, Gabriele, Sikorska, Karolina, Alkemade, Maartje, Opdam, Mark, Schagen van Leeuwen, Jules H., Schreuder, Henk W. R., Hermans, Ralph H. M., de Hingh, Ignace H. J. T., Mom, Constantijne H., Arts, Henriette J. G., van Ham, Maaike, van Dam, Peter, Vuylsteke, Peter, Sanders, Joyce

Source: International Journal of Cancer; Oct2022, Vol. 151 Issue 8, p1394-1404, 11p

Subject Terms: PERITONEAL cancer, CLINICAL trials, HYPERTHERMIC intraperitoneal chemotherapy, DNA copy number variations, OVARIAN cancer, PROPORTIONAL hazards models

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial.

Authors: Aronson, S Lot^1,2 (AUTHOR), Lopez-Yurda, Marta³ (AUTHOR), Koole, Simone N^1,2 (AUTHOR), Schagen van Leeuwen, Jules H⁴ (AUTHOR), Schreuder, Hendrik W R⁵ (AUTHOR), Hermans, Ralph H M⁶ (AUTHOR), de Hingh, Ignace H J T^7,8 (AUTHOR), van Gent, Mignon D J M^9,10 (AUTHOR), Arts, Henriëtte J G¹¹ (AUTHOR), van Ham, Maaike A P C¹² (AUTHOR), van Dam, Peter A¹³ (AUTHOR), Vuylsteke, Peter^14,15 (AUTHOR), Aalbers, Arend G J¹⁶ (AUTHOR), Verwaal, Victor J¹⁷ (AUTHOR), Van de Vijver, Koen K¹⁸ (AUTHOR), Aaronson, Neil K¹⁹ (AUTHOR), Sonke, Gabe S^1,2 (AUTHOR), van Driel, Willemien J^1,10 (AUTHOR) w.v.driel@nki.nl

Source: Lancet Oncology. Oct2023, Vol. 24 Issue 10, p1109-1118. 10p.

Subject Terms: *HYPERTHERMIC intraperitoneal chemotherapy, *CLINICAL trials, *CANCER patients, *CYTOREDUCTIVE surgery, *SURVIVAL analysis (Biometry)

Geographic Terms: NETHERLANDS, BELGIUM